Artwork

Content provided by Back Bay Life Science Advisors, Jonathan P. Gertler, and Peter Bak. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Back Bay Life Science Advisors, Jonathan P. Gertler, and Peter Bak or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The Transactional Landscape Of ADCs: The Powerhouse of Antibody Drug Conjugates

25:54
 
Share
 

Manage episode 375527925 series 2991382
Content provided by Back Bay Life Science Advisors, Jonathan P. Gertler, and Peter Bak. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Back Bay Life Science Advisors, Jonathan P. Gertler, and Peter Bak or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode, Dr. Peter Bak is joined by Trent Gordon and Dr. Mavra Nasir as they discuss their Bioprocess Online article published earlier this year, “The Transactional Landscape of ADCs: A Payday for Payloads.” This conversation explores the dynamics and data within the emerging ADC field, including:

  • Background information on the class of therapeutics known as ADCs, which have been on the market since 2000
  • The number of headlines around ADCs lately, especially the standing ovation the data from Enhertu received at ASCO in 2022, making waves in breast cancer treatment
  • Deal structures and the BD side of ADCs, and their extended revenue generation potential
  • Where the field is headed, in terms of clinical, BD and commercial standpoints

Read and connect with our authors: The Transactional Landscape Of ADCs: A Payday for Payloads

  continue reading

28 episodes

Artwork
iconShare
 
Manage episode 375527925 series 2991382
Content provided by Back Bay Life Science Advisors, Jonathan P. Gertler, and Peter Bak. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Back Bay Life Science Advisors, Jonathan P. Gertler, and Peter Bak or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode, Dr. Peter Bak is joined by Trent Gordon and Dr. Mavra Nasir as they discuss their Bioprocess Online article published earlier this year, “The Transactional Landscape of ADCs: A Payday for Payloads.” This conversation explores the dynamics and data within the emerging ADC field, including:

  • Background information on the class of therapeutics known as ADCs, which have been on the market since 2000
  • The number of headlines around ADCs lately, especially the standing ovation the data from Enhertu received at ASCO in 2022, making waves in breast cancer treatment
  • Deal structures and the BD side of ADCs, and their extended revenue generation potential
  • Where the field is headed, in terms of clinical, BD and commercial standpoints

Read and connect with our authors: The Transactional Landscape Of ADCs: A Payday for Payloads

  continue reading

28 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide